Global leader in serving science, providing equipment, instruments, reagents, and consumables for laboratories worldwide.
Symbol: | TMO |
---|---|
Quote: | 532.55 |
Change: | -5.28 |
Change %: | -0.98% |
High: | 542.62 |
Low: | 532.01 |
Open: | 538.36 |
---|---|
Volume: | 1,613,764 |
52 Week: | 493.30-627.88 |
P/E Ratio: | 32.26 |
EPS: | 16.51 |
Market Cap: | 200.91 B |
Thermo Fisher Scientific Inc. is a global leader in providing a wide array of solutions for life sciences, analytical instruments, specialty diagnostics, and laboratory products and services. The company's Life Sciences Solutions segment is dedicated to supplying reagents, instruments, and consumables essential for biological and medical research. These products support drug and vaccine discovery, as well as the diagnosis of infections and diseases across pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government sectors.
In the Analytical Instruments segment, Thermo Fisher Scientific offers a comprehensive range of instruments, consumables, software, and services. These are utilized in laboratories, production lines, and field settings, catering to pharmaceutical, biotechnology, academic, government, environmental, and industrial research applications, as well as clinical laboratories.
The company's Specialty Diagnostics segment focuses on providing immunodiagnostic reagent kits, calibrators, controls, and various healthcare products. It serves markets such as allergy and asthma testing, autoimmunity tests, organ transplant diagnostics, and clinical microbiology. Thermo Fisher Scientific also operates in the Laboratory Products and Services segment, offering a broad portfolio including laboratory refrigeration, ultralow-temperature freezers, biological safety cabinets, water analysis instruments, and a range of laboratory consumables and chemicals. With a commitment to innovation and customer satisfaction, the company reaches its global clientele through direct sales, electronic commerce, third-party distributors, and catalogs, supported by a strategic alliance with the University of California, San Francisco.
Exchange: | NYSE |
---|---|
Beta: | 0.776 |
Industry: | Medical - Diagnostics & Research |
Sector: | Healthcare |
Employees: | 125,000 |
IPO Date: | Mar 17, 1980 |
![]() WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025 at 9:10 a.m. (ET). The live webcast of the presentation can be acces... 5 hours ago |
![]() The Investment Committee give you their top stocks to watch for the second half. 3 days ago |
![]() WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.43 per common share, payable on April 15, 2025, to shareholders of record as of March 14, 2025. This reflects an 10% increase over the previous divide... 4 days ago |
![]() WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced Karen S. Lynch has been elected to its board of directors, effective February 19, 2025. The appointment brings the total number of Thermo Fisher board members to 12. Ms. Lynch is a seasoned health care executive with over ... 4 days ago |
![]() Thermo Fisher's Invitrogen EVOS S1000 Spatial Imaging System addresses the limitations of current fluorescent microscopy technologies. 11 days ago |